KORU Medical Systems Inc (NAS:KRMD)

Q3 2025 KORU Medical Systems Inc Earnings Call Transcript

Nov 12, 2025 / 09:30 PM GMT

Release Date Price: $3.78 (+1.34%)

Transcript 10-Q8-K

Key Points

Positve

KORU Medical Systems Inc (KRMD) achieved its second consecutive quarter with more than $10 million in revenue, representing a 27% year-over-year growth.
The core subcutaneous immunoglobulin (SCIG) business grew by 30%, driven by international expansion and strong patient growth.
The company announced two new PST collaborations, expanding its pipeline and reaching additional patient populations.
KORU Medical Systems Inc (KRMD) completed a US-based oncology study, validating its value proposition in oncology infusion centers.
The company raised its full-year revenue guidance to $40.5 to $41 million, reflecting confidence in continued execution and growth.

Negative

Domestic revenue declined by 5% due to a US distributor reducing their on-hand inventory levels.
Gross margin decreased by 320 basis points from the prior year, driven by higher manufacturing costs and lower yields.
There was a geographic revenue imbalance, with international revenue growing by 230% while domestic revenue declined.
Two previously announced collaborations had their launch dates pushed into 2027, affecting the pipeline timeline.
The company faced challenges with a distributor selling products across geographies, impacting revenue figures.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KRMD.OQ - KORU Medical Systems Inc
Q3 2025 KORU Medical Systems Inc Earnings Call
Nov 12, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to Kum Medical Systems 3rd quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press 0 on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to Louisa Smith, head of investor relations.

Thank you. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good afternoon,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.